Efficacy of two ethanol-based skin antiseptics on the forehead at shorter application times by Kampf, Günter et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Efficacy of two ethanol-based skin antiseptics on the forehead at 
shorter application times
Günter Kampf*1,2, Frank-Albert Pitten2,3, Peter Heeg4 and 
Bärbel Christiansen5
Address: 1Bode Chemie GmbH & Co. KG, Scientific Affairs, Melanchthonstrasse 27, 22525 Hamburg, Germany, 2Institute for Hygiene and 
Environmental Medicine, Ernst Moritz Arndt University, Walther-Rathenau-Str. 49a, 17489 Greifswald, Germany, 3Institute for Hospital Hygiene 
and Infection Control, Siemensstrasse 18, 35394 Giessen, Germany, 4Institute for Medical Microbiology and Hygiene, University Hospital, 
Elfriede-Aulhorn-Strasse 6, 72076 Tübingen, Germany and 5Institute for Hygiene, University Hospital Schleswig-Holstein, Campus Kiel, 
Brunswiker Strasse 4, 24105 Kiel, Germany
Email: Günter Kampf* - guenter.kampf@bode-chemie.de; Frank-Albert Pitten - pitten@iki-giessen.de; Peter Heeg - Peter.Heeg@med.uni-
tuebingen.de; Bärbel Christiansen - bchristiansen@hygiene.uni-kiel.de
* Corresponding author    
Abstract
Background: Recent research suggests that alcohol-based skin antiseptics exhibit their efficacy on
the resident skin flora of the forehead in less than 10 minutes. That is why we have looked at the
efficacy of two ethanol-based skin antiseptics applied for 10, 2.5 and 2 minutes on skin with a high
density of sebaceous glands. Each experiment was performed in a reference-controlled cross-over
design with at least 20 participants. Application of isopropanol (70%, v/v) for 10 minutes to the
forehead served as the reference treatment. The clear (skin antiseptic A) and coloured
preparations (skin antiseptic B) contain 85% ethanol (w/w). Pre-values and post-values (immediately
after the application and after 30 min) were obtained by swabbing a marked area of 5 cm2 for about
10 s. Swabs were vortexed in tryptic soy broth containing valid neutralizing agents. After serial
dilution aliquots were spread on tryptic soy agar. Colonies were counted after incubation of plates
at 36°C for 48 h. The mean log10 reduction of bacteria was calculated. The Wilcoxon matched-
pairs signed-ranks test was used for a comparison of treatments.
Results: Skin antiseptic A applied for 10 min was significantly more effective than the reference
treatment. When applied for 2.5 min (three experiments) it was significantly more effective than
the reference treatment immediately after application (2.7 versus 2.2 log10 reduction; p < 0.001)
and equally effective after 30 min (2.8 versus 2.6 log10 reduction; p = 0.053). Skin antiseptic B
applied for 2.5 min (three experiments) was significantly more effective than the reference
treatment both immediately after application (2.3 versus 1.9 log10 reduction; p < 0.001) and after
30 min (2.5 versus 2.1 log10 reduction; p = 0.002).
Conclusion: The clear and coloured skin antiseptics applied for 2.5 min on the skin of the
forehead fulfilled the efficacy requirements for skin antisepsis. The shorter application time on skin
with a high density of sebaceous glands will allow to act more efficiently in clinical practice.
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Background
Surgical site infections are among the most common
infectious complications of treatment in the hospital [1].
Up to 5.2% (USA) or 7.2% (Germany) of surgical patients
in hospitals develop a surgical site infection during or
after hospital stay depending on the type of operation [2-
4]. The rate for surgical site infections after specific indica-
tor operations, however, is lower [5]. Surgical site infec-
tions have a huge economic impact because patients
remain on average 6.5 days longer in the hospital and are
five times as often re-admitted to the hospital. They are
60% more likely to be treated on an intensive care unit. A
surgical site infection costs approximately € 3.000 [6],
depending largely on the type of underlying operation [7].
The crude odds ratio for hospital deaths associated with
surgical site infections is 2.67 [8]. The resident skin flora
has also been described to cause serious infectious com-
plications [9,10]. In order to reduce the risk for surgical
site infections a skin disinfection prior to the penetration
of the skin is recommended among many other measures
[11].
In central Europe, preparations based on ethanol or iso-
propanol are commonly used for skin antisepsis. There is
currently no European norm available to determine the
efficacy of preparations for skin antisepsis. That is why the
efficacy of a preparation is commonly determined accord-
ing to the test method of the German Society for Hygiene
and Microbiology (DGHM) which was first described in
1991 [12]. It requires the comparison to a reference treat-
ment in a cross-over design [13]. On skin with a high den-
sity of sebaceous glands the application time in the test
method is 10 minutes for both the skin antiseptic and the
reference alcohol. That is why in clinical practice the rec-
ommended application time for a skin antiseptic is usu-
ally 10 minutes on skin with a high density of sebaceous
glands. The efficacy of alcohol-based skin antiseptics
applied for shorter application times has first been stud-
ied in 2006 (Kramer; unpublished data). It was demon-
strated with some alcohol-based skin antiseptics that a 3
min application is equally effective on the forehead to a
10 min application.
Based on these findings we investigated the efficacy of two
new skin antiseptics based on 85% ethanol on the resi-
dent flora of the forehead with application times of 10,
2.5 and 2 min.
Methods
Design and preparation of subjects
Each experiment was performed in a reference-controlled
cross-over design [13]. A minimum of 20 volunteers was
recruited per experiment. Only participants with healthy
skin on the forehead were selected (no injury, eczema or
other inflammatory skin disease). Subjects were excluded
when they took antibiotics or had used a disinfectant or
antiseptic solution within the last three days before an
experiment. The hair was clipped or tied around so that it
would not touch the skin of the forehead during the inves-
tigation. The skin of the forehead was randomly divided
into five areas of approximately five cm2. One area was
chosen to determine the baseline bacterial density. Two
areas were used for application of the reference alcohol
(10 minutes), one for each of the different sampling
times. Another two test areas were used for application of
the skin antiseptic (2, 2.5 or 10 minutes), one for each of
the different sampling times. A cotton swab was soaked
with the skin antiseptic and swabbed over the marked test
field. The procedure was repeated up to five times in order
to keep the skin moist with the skin antiseptic for the
entire application time. Ethical approval for studying the
efficacy for skin antisepsis was obtained from the ethics
committee of the University Hospital Kiel, Germany. The
study was conducted in accordance with the ethical prin-
ciples that have their origins in the current version of the
Declaration of Helsinki (52nd WMA General Assembly,
Edinburgh, Scotland, October 2000). Informed consent
was obtained from each participant.
Products and application
The following preparations were used: propan-2-ol (70%,
v/v) as the reference alcohol, a clear skin antiseptic based
on 85% [w/w] ethanol (skin antiseptic A), and a coloured
skin antiseptic based on 85% [w/w] ethanol (skin antisep-
tic B). The coloured skin antiseptic contains in addition
the dyes E 104 and E 131, the thickener polyvinyl pyrro-
lidon. Both skin antiseptics were manufactured by Bode
Chemie GmbH & Co. KG, Hamburg, Germany.
The clear skin antiseptic has been shown before with an
application time of 3 to 5 min to have a superior efficacy
on the bacterial flora of the forehead (Kramer; unpub-
lished data). In out study it was applied to the skin of the
forehead for 10 min and application times shorter than 3
min in order to identify the shortest application time with
an efficacy equivalent to the reference procedure. The col-
oured skin antiseptic was only investigated with the appli-
cation time in which the clear skin antiseptic was found to
have an efficacy equivalent to the reference procedure in
order to demonstrate that the addition of the dyes and the
thickener does not impair the efficacy significantly. The
reference alcohol was always applied for 10 min to the
skin of the forehead according to the testing guideline
[13].
Determination of the pre-values and post-values
Sampling and cultivation were done according to the test
method of the German Society for Hygiene and Microbi-
ology [13]. Each sampling area was marked so that the
standard size of 5 cm2 was clearly visible. A cotton swabBMC Microbiology 2007, 7:85 http://www.biomedcentral.com/1471-2180/7/85
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was soaked in tryptic soy broth (TSB). The sampling area
was rigorously rubbed for about 10 s as described before
[14]. Care was taken to ensure that the swab was only
rubbed within the marked skin area. The swab was trans-
ferred into 5 ml TSB containing a combination of neutral-
izing agents for inactivation of residual biocidal activity
[15]. In laboratory A the following neutralizing agents
were used: 3% Tween 80, 0.3% lecithin and 0.1%
cysteine. In laboratories B and C the following neutraliz-
ing agents were used: 3% Tween 80, 3% saponine, 0.1%
histidine and 0.1% cysteine. Both combinations of neu-
tralizing agents were found to be valid for neutralization
of 85% ethanol (data not shown). The tube was vortexed
for 30 s with a high frequency. A serial dilution was done
in TSB. From appropriate dilution steps aliquots of 1 ml
were spread on tryptic soy agar (TSA) in duplicate.
Disinfection phase
Two marked skin areas on the forehead were treated with
the reference alcohol, two other ones with one of the two
skin antiseptics. After each type of treatment two samples
were taken (post-values). The first sample was taken
immediately after completion of the application (10, 2.5
or 2 min after beginning of the application). The second
sample was taken 30 minutes after beginning of the appli-
cation (20, 27.5 or 28 min after completion of applica-
tion). Between each product application, a rest period of
at least one week elapsed in order to allow the reconstitu-
tion of normal skin flora.
Calculation of bacterial reduction
The plates were incubated for a total of 48 h at 36°C, and
the colony-forming units (CFU) from plates were
counted. For calculation purposes, plate count values ≤
300 CFU were accepted. Plate count values of 0 were reset
to 1, because the log10 of 0 is undefined, and the log10 of
1 = 0. The weighted mean of CFU was calculated taking
into account the number of CFU per plate and the corre-
sponding dilution step. The weighted mean was multi-
plied by the dilution factor in order to obtain the number
of CFU per mL in the sampling liquid. All pre- and post-
values were expressed as log10 values. For each sample
from each volunteer, the logarithmic reduction factor (RF)
was calculated as the difference between the log10 baseline
value and the log10 post-values.
Statistics
A product is considered effective for skin antisepsis if the
mean RF at both sampling times is not significantly lower
than the corresponding mean RF of the 10 min reference
treatment (one sided Wilcoxon matched-pairs signed-
ranks test; p > 0.1). Differences of all other means were
investigated by the two sided Wilcoxon matched-pairs
signed-ranks test [13]. A p-value < 0.05 was chosen to
indicate a significant difference.
Results
Application time of 10 min
Two experiments were performed. The clear skin antisep-
tic A reduced the bacterial density on the forehead by 2.72
to 2.89 log10-steps (10 min after beginning of the applica-
tion) and 2.39 to 3.45 log10-steps (30 min after beginning
of the application). The skin antiseptic was either equally
effective or more effective in comparison to the reference
procedure (Table 1). Overall, application of the clear skin
antiseptic A for 10 min yielded a significantly higher
reduction of the resident bacterial flora in comparison to
the 10 min reference procedure (p < 0.01; Wilcoxon
matched-pairs signed-rank test).
Application time of 2.5 min
Three experiments were performed with the clear skin
antiseptic A (Table 2). In study facility A, the clear skin
antiseptic A was significantly more effective at both sam-
pling points (p < 0.001). In study facility B, the clear skin
antiseptic A was significantly more effective (2.5 min after
beginning of the application: mean RF of 3.17 versus 2.79;
p = 0.028) and equally effective 30 min after beginning of
the application (mean RF of 2.92 versus 3.02; p = 0.58).
In study facility C, the clear skin antiseptic A was equally
effective (2.5 min after beginning of the application:
mean RF of 1.86 versus 1.77; 30 min after beginning of
the application: mean RF of 2.39 versus 2.40); both differ-
ences were not significant. Overall, application of the
clear skin antiseptic A lead to a mean log10-reduction of
2.74 (2.5 min after beginning of the application) which is
Table 1: Efficacy of a clear skin antiseptic on the forehead applied for 10 min
Study facility and 
number of subjects
Sampling time after 
beginning of application
Mean pre-value of 
bacterial density
RF (mean and stdev) of 
reference treatment (10 
min exposure)
RF (mean and stdev) of 
clear skin antiseptic A 
(10 min exposure)
p-value
A (n = 20) 10 min 3.88 ± 0.79 2.15 ± 0.78 2.72 ± 0.99 0.036
30 min 1.94 ± 1.02 2.39 ± 0.97 0.012
B (n = 20) 10 min 3.81 ± 0.45 2.44 ± 0.81 2.89 ± 0.70 0.10
30 min 2.97 ± 0.96 3.45 ± 0.61 0.044
All (n = 40) 10 min n.a. 2.29 ± 0.80 2.81 ± 0.85 0.005
30 min 2.46 ± 1.11 2.92 ± 0.96 0.004BMC Microbiology 2007, 7:85 http://www.biomedcentral.com/1471-2180/7/85
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significantly higher compared to the 10 min reference dis-
infection (mean log10-reduction of 2.19; p < 0.001). 30
min after beginning of the application the clear skin anti-
septic A was equally effective to the reference treatment
(2.77 versus 2.59; p = 0.053).
The coloured skin antiseptic B was studied in three exper-
iments (Table 3). In study facility A application of the col-
oured skin antiseptic B was significantly more effective
than the 10 min reference procedure both 2.5 min after
beginning of the application (3.25 versus 2.50 log10
reduction; p < 0.001) and after 30 min (2.96 versus 2.59
log10 reduction; p = 0.006). In study facility B it was also
significantly more effective both 2.5 min after beginning
of the application (2.45 versus 1.94 log10 reduction; p =
0.007) and 30 min after beginning of the application
(2.43 versus 1.86 log10 reduction; p = 0.01). In study facil-
ity C it was equally effective 2.5 min after beginning of the
application (1.21 versus 1.26 log10 reduction; p = 0.60)
and 30 min after beginning of the application (2.09 versus
1.93 log10 reduction; p = 0.83). Overall, application of the
coloured skin antiseptic B for 2.5 min yielded a signifi-
cantly higher reduction of the resident bacterial flora in
comparison to the 10 min reference procedure (p < 0.05).
Application time of 2 min
Two experiments were performed with the clear skin anti-
septic A (Table 4). In study facility A, the clear skin anti-
septic A was significantly more effective at both sampling
points (p ≤ 0.001). In study facility B, the clear skin anti-
septic A was equally effective 2 min after beginning of the
application (mean RF of 2.08 versus 2.03; p = 0.55) and
significantly less effective 30 min after beginning of the
application (mean RF of 2.13 versus 2.53; p < 0.1). Over-
all, application of the clear skin antiseptic A lead to a
mean log10-reduction of 2.57 (2 min after beginning of
the application) which is significantly higher compared to
the 10 min reference disinfection (mean log10-reduction
of 2.05; p = 0.002). 30 min after beginning of the applica-
tion the clear skin antiseptic A was equally effective to the
reference treatment (2.59 versus 2.44 log10 reduction; p =
0.17).
Discussion
For the first time we were able to demonstrate that the effi-
cacy of an ethanol-based skin antiseptic is achieved on the
forehead within 2.5 min and does not require a 10 min
application time. This could be shown for a clear and a
coloured skin antiseptic both based on 85% (w/w) etha-
Table 2: Efficacy of a clear skin antiseptic on the forehead applied for 2.5 min
Study facility and 
number of subjects
Sampling time after 
beginning of application
Mean pre-value of 
bacterial density
RF (mean and stdev) of 
reference treatment (10 
min exposure)
RF (mean and stdev) of 
clear skin antiseptic A 
(2.5 min exposure)
p-value
A (n = 20) 10 min/2.5 min 3.97 ± 0.47 2.08 ± 0.86 3.33 ± 0.38 < 0.001
30 min 2.36 ± 0.63 3.05 ± 0.49 < 0.001
B (n = 20) 10 min/2.5 min 3.57 ± 0.48 2.79 ± 0.92 3.17 ± 0.67 0.028
30 min 3.02 ± 0.69 2.92 ± 0.69 0.58
C (n = 23) 10 min/2.5 min 4.21 ± 0.71 1.77 ± 1.18 1.86 ± 1.40 0.51
30 min 2.40 ± 1.29 2.39 ± 1.49 0.84
All (n = 63) 10 min n.a. 2.19 ± 1.08 2.74 ± 1.16 < 0.001
30 min 2.59 ± 0.97 2.77 ± 1.04 0.053
Table 3: Efficacy of a coloured skin antiseptic on the forehead applied for 2.5 min
Study facility and 
number of subjects
Sampling time after 
beginning of application
Mean pre-value of 
bacterial density
RF (mean and stdev) of 
reference treatment (10 
min exposure)
RF (mean and stdev) of 
coloured skin antiseptic B 
(2.5 min exposure)
p-value
A (n = 20) 10 min/2.5 min 3.79 ± 0.54 2.50 ± 0.70 3.25 ± 0.50 < 0.001
30 min 2.59 ± 0.69 2.96 ± 0.57 0.006
B (n = 20) 10 min/2.5 min 3.36 ± 0.81 1.94 ± 0.59 2.45 ± 0.81 0.007
30 min 1.86 ± 0.74 2.43 ± 1.08 0.01
C (n = 20) 10 min/2.5 min 4.72 ± 0.60 1.26 ± 0.78 1.21 ± 0.64 0.60
30 min 1.93 ± 1.18 2.09 ± 1.44 0.83
All (n = 60) 10 min/2.5 min n.a. 1.90 ± 0.85 2.30 ± 1.07 < 0.001
30 min 2.13 ± 0.94 2.49 ± 1.13 0.002BMC Microbiology 2007, 7:85 http://www.biomedcentral.com/1471-2180/7/85
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nol. Extending the application time with any of the two
skin antiseptics beyond 2.5 min has, based on our data,
no additional effect on the bacterial density and can there-
fore be regarded as unnecessary. Shorter application times
for skin antiseptics have been recommended as long as
there is sound evidence that the efficacy is equal to the ref-
erence procedure and the skin antiseptic is approved as a
medicinal product [16].
The results obtained with the 10 min reference disinfec-
tion on the skin of the forehead indicate some outcome
variability among the ten experiments. The lowest mean
log10 reduction obtained with the reference alcohol, meas-
ured as the immediate effect, was 1.26 ± 0.78, the highest
mean was 2.79 ± 0.92. Similar results for reference alcohol
have been described before [14,17,18]. A certain outcome
variability has to be expected when the effect of antiseptics
is measured on the resident bacterial skin flora without an
artificial contamination. A similar test principle can be
found in surgical hand disinfection when the efficacy of a
hand rub is also measured against the resident hand flora.
The variability of the outcome obtained with a surgical
hand disinfection reference procedure is also relatively
high [19]. When hands, however, are artificially contami-
nated (e.g. with Escherichia coli) the variability of the refer-
ence procedure efficacy is remarkably lower which can be
explained by the standardized size of the high inoculum
[20,21]. That is why it is essential to study the efficacy of
antiseptics in a cross-over design in order to better come
around the inevitable outcome variability of the reference
procedure.
The bacterial biota in normal superficial skin are highly
diverse [22]. Especially the skin on the forehead is known
to have a stable and dense bacterial population which is
rather difficult to reduce [23,24]. This is most likely
explained by the high number of sebaceous glands excret-
ing lipids [25,26]. Alcohol, however, has been described
to penetrate into the deeper layers of the stratum corneum
where it exhibits an effect which is similar to the one on
the surface of the stratum corneum [27]. Other investiga-
tors have also studied the efficacy of skin antiseptics on
the resident bacterial flora of the forehead and found a
reduction of the resident skin flora in the same range [28-
30]. The skin of the forehead is known to be an area with
a higher density of resident skin bacteria compared to
other areas of human skin [31]. Similar mean reductions
with various types of skin antiseptics were found on
abdominal skin [32]. It is known that alcohol does not
completely eliminate the resident flora on the forehead
[33].
Most skin antiseptics in central Europe are currently rec-
ommended with a 10 min application time on skin with
a high density of sebaceous glands [34]. The reason for the
10 min application time is that they are usually tested for
efficacy according to the method of the DGHM which
only allows a 10 min application time [13]. To our knowl-
edge this is one of the first investigations with skin anti-
septics to identify a shorter but equally effective
application time for specific formulations. Recent changes
in surgical hand disinfection indicate that there is cur-
rently a trend to identify the application time which is
truly necessary for an antiseptic preparation to fulfill the
defined efficacy requirements [35,36]. This development
in surgical hand disinfection has also been recognized and
accepted by the relevant infection control societies in Ger-
many [37,38] and is in principal considered to be an
important step for evidence-based recommendations in
infection control [39].
The clinical advantage is substantial if the application
time on skin with a high density of sebaceous glands is
reduced from 10 to 2.5 min without any loss of efficacy.
But this will only be possible for preparations with sound
evidence that a short application time yields the same effi-
cacy as a long application time. A short application time
will allow to perform an intervention with less delay not
only in neurosurgery or plastic facial surgery but espe-
cially in skin antisepsis prior to lumbar punctures, epi-
dural or peridural anaesthesia which may be particularly
valuable in emergency procedures.
Table 4: Efficacy of a clear skin antiseptic on the forehead applied for 2 min
Study facility and 
number of subjects
Sampling time after 
beginning of application
Mean pre-value of 
bacterial density
RF (mean and stdev) of 
reference treatment (10 
min exposure)
RF (mean and stdev) of 
clear skin antiseptic A (2 
min exposure)
p-value
A (n = 20) 10 min/2 min 3.97 ± 0.47 2.08 ± 0.86 3.05 ± 0.40 0.001
30 min 2.36 ± 0.63 3.05 ± 0.49 < 0.001
B (n = 20) 10 min/2 min 3.37 ± 0.62 2.03 ± 1.30 2.08 ± 0.88 0.55
30 min 2.53 ± 1.07 2.13 ± 1.00 < 0.1
All (n = 40) 10 min n.a. 2.05 ± 1.08 2.57 ± 0.84 0.002
30 min 2.44 ± 0.87 2.59 ± 0.91 0.17BMC Microbiology 2007, 7:85 http://www.biomedcentral.com/1471-2180/7/85
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Conclusion
The clear and coloured skin antiseptics which were tested
in our study and which were applied for 2.5 min on the
skin of the forehead fulfilled the efficacy requirements for
skin antisepsis. The shorter application time on skin with
a high density of sebaceous glands will allow to act more
efficiently in clinical practice.
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